Evidence map›Paper›PMID 34066574›Full record

ArticleDiagnostics (Basel, Switzerland)2021

A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [

Hong Hua Piao, Subin Jeon, Su Woong Yoo, Young Jae Ryu, Dong-Yeon Kim, Ayoung Pyo, Hee-Seung Bom, Jung-Joon Min, Seong Young Kwon

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hong Hua PiaoDepartment of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Korea.ORCID 0000-0002-7421-9270
Subin JeonDepartment of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Korea.
Su Woong YooDepartment of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Korea.ORCID 0000-0002-6810-1727
Young Jae RyuDepartment of Surgery, Chonnam National University Medical School and Hwasun Hospital, Hwasun-gun 58128, Korea.ORCID 0000-0001-7302-8109
Dong-Yeon KimCollege of Pharmacy and Research Institute of Pharmaceutical Science, Gyeongsang National University, Jinju 52828, Korea.
Ayoung PyoDepartment of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Korea.
Hee-Seung BomDepartment of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Korea.
Jung-Joon MinDepartment of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Korea.
Seong Young KwonDepartment of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Korea.ORCID 0000-0002-2832-896X
Chonnam National University Hwasun Hospital · KRGyeongsang National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated whether an indication for [

Indexed as

[18F]FDG PET/CTlymph node ratiopapillary thyroid cancerpersistent diseasethyroglobulin

Identifiers

PMID34066574
PMCPMC8148441
OpenAlexW3159677822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.